Follow The Filings

NMR Nomura

Nomura earnings company data as of 3:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 0.20 — —
Rev — — —

Insider trades

Open-market buys and sales by NMR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NMR insider trades
  • $3,899 bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Masahiro Ishizuka Director
    Buy
    $1,917 238 shares at $8.05 +244% to stake
    Traded Mar 25 Filed Mar 27
  2. Yukiko Ozaki See Remarks
    Buy
    $64 8 shares at $8.05 +15% to stake
    Traded Mar 25 Filed Mar 26

Also filed in the last 12 months, not counted as buying or selling: 37 stock grants, 26 option exercises, 16 share withholdings for taxes, and 10 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
6-K FORM 6-K
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
6-K FORM 6-K
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT
424B2 PRICING SUPPLEMENT

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.